CardiovascularINJECTIONStandard
NUTRILIPID 20%
SOYBEAN OIL
Standard Dose
20%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview NUTRILIPID 20% is listed in Drugs@FDA under application 019531 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SOYBEAN OIL Form and strength INJECTABLE;INJECTION - 20% Sponsor B BRAUN Submission history Latest submission status date: 2025-07-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview NUTRILIPID 20% is listed in Drugs@FDA under application 019531 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SOYBEAN OIL Form and strength INJECTABLE;INJECTION - 20% Sponsor B BRAUN Submission history Latest submission status date: 2025-07-24 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.